Skip to main content
Erschienen in: World Journal of Urology 2/2012

01.04.2012 | Topic paper

Familial risk and familial survival in prostate cancer

verfasst von: Kari Hemminki

Erschienen in: World Journal of Urology | Ausgabe 2/2012

Einloggen, um Zugang zu erhalten

Abstract

Objectives

The Swedish Family-Cancer Database has been the major source of population-based prospective data on familial risks on most cancers, including prostate cancer. In the present review, I focus on three lines of family studies with novel results.

Methods

The covered studies originate from the same database with publication dates spanning a period of somewhat over 3 years. Age-specific hazard ratios (HRs) of incident prostate cancer and fatal prostate cancer were determined according to the number of affected relatives. Cumulative risks for incidence and death were calculated for the various types of families. Finally, data on the familial association of prostate cancer with some other cancers were reviewed.

Results

If the father had prostate cancer, the HR for sons was 2.1 and it increased to 17.7 when three brothers were affected. The highest HR (23) was observed for men before age 60 years with three affected brothers. The patterns for fatal familial prostate cancer were similar. Other reviewed sets of data showed evidence for the familial concordance of good and poor survival in prostate cancer. Familial risks were somewhat higher for fatal than for incident prostate cancer, suggesting that fatal prostate cancers may be a genetic subgroup.

Conclusions

Considering the high familial risks in fatal prostate cancer, family history remains an important prognostic piece of information useful for clinical genetic counseling. Obviously, preventive measures for at-risk men are needed but these are beyond the present paper. Starting screening before any prostate cancers are diagnosed in a family appears counterproductive.
Literatur
1.
Zurück zum Zitat Hemminki K, Sundquist J, Lorenzo Bermejo J (2008) How common is familial cancer. Ann Oncol 19:163–167PubMedCrossRef Hemminki K, Sundquist J, Lorenzo Bermejo J (2008) How common is familial cancer. Ann Oncol 19:163–167PubMedCrossRef
2.
Zurück zum Zitat Hemminki K, Sundquist J, Lorenzo Bermejo J (2008) Familial risks for cancer as the basis for evidence-based clinical referral and counseling. The Oncologist 13:239–247PubMedCrossRef Hemminki K, Sundquist J, Lorenzo Bermejo J (2008) Familial risks for cancer as the basis for evidence-based clinical referral and counseling. The Oncologist 13:239–247PubMedCrossRef
3.
Zurück zum Zitat Goldgar DE, Easton DF, Cannon-Albright LA, Skolnick MH (1994) Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst 86:1600–1607PubMedCrossRef Goldgar DE, Easton DF, Cannon-Albright LA, Skolnick MH (1994) Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst 86:1600–1607PubMedCrossRef
4.
Zurück zum Zitat Bray F, Klint A, Gislum M et al (2010) Trends in survival of patients diagnosed with male genital cancers in the Nordic countries 1964–2003 followed up until the end of 2006. Acta Oncol 49:644–654PubMedCrossRef Bray F, Klint A, Gislum M et al (2010) Trends in survival of patients diagnosed with male genital cancers in the Nordic countries 1964–2003 followed up until the end of 2006. Acta Oncol 49:644–654PubMedCrossRef
5.
6.
Zurück zum Zitat Liede A, Karlan BY, Narod SA (2004) Cancer risks for male carriers of germline mutations in BRCA1 or BRCA2: a review of the literature. J Clin Oncol 22:735–742PubMedCrossRef Liede A, Karlan BY, Narod SA (2004) Cancer risks for male carriers of germline mutations in BRCA1 or BRCA2: a review of the literature. J Clin Oncol 22:735–742PubMedCrossRef
7.
Zurück zum Zitat Amundadottir LT, Thorvaldsson S, Gudbjartsson DF et al (2004) Cancer as a complex phenotype: pattern of cancer distribution within and beyond the nuclear family. PLoS Med 1:e65PubMedCrossRef Amundadottir LT, Thorvaldsson S, Gudbjartsson DF et al (2004) Cancer as a complex phenotype: pattern of cancer distribution within and beyond the nuclear family. PLoS Med 1:e65PubMedCrossRef
8.
Zurück zum Zitat Chung CC, Magalhaes WC, Gonzalez-Bosquet J, Chanock SJ (2010) Genome-wide association studies in cancer–current and future directions. Carcinogenesis 31:111–120PubMedCrossRef Chung CC, Magalhaes WC, Gonzalez-Bosquet J, Chanock SJ (2010) Genome-wide association studies in cancer–current and future directions. Carcinogenesis 31:111–120PubMedCrossRef
9.
Zurück zum Zitat Fletcher O, Houlston RS (2010) Architecture of inherited susceptibility to common cancer. Nat Rev Cancer 10:353–361PubMedCrossRef Fletcher O, Houlston RS (2010) Architecture of inherited susceptibility to common cancer. Nat Rev Cancer 10:353–361PubMedCrossRef
10.
Zurück zum Zitat Hemminki K, Rawal R, Bermejo JL (2005) Prostate cancer screening, changing age-specific incidence trends and implications on familial risk. Int J Cancer 113:312–315PubMedCrossRef Hemminki K, Rawal R, Bermejo JL (2005) Prostate cancer screening, changing age-specific incidence trends and implications on familial risk. Int J Cancer 113:312–315PubMedCrossRef
11.
Zurück zum Zitat Brandt A, Bermejo JL, Sundquist J, Hemminki K (2010) Age-specific risk of incident prostate cancer and risk of death from prostate cancer defined by the number of affected family members. Eur Urol 58:275–280PubMedCrossRef Brandt A, Bermejo JL, Sundquist J, Hemminki K (2010) Age-specific risk of incident prostate cancer and risk of death from prostate cancer defined by the number of affected family members. Eur Urol 58:275–280PubMedCrossRef
12.
Zurück zum Zitat Brandt A, Bermejo JL, Sundquist J, Hemminki K (2009) Age at diagnosis and age at death in familial prostate cancer. Oncologist 14:1209–1217PubMedCrossRef Brandt A, Bermejo JL, Sundquist J, Hemminki K (2009) Age at diagnosis and age at death in familial prostate cancer. Oncologist 14:1209–1217PubMedCrossRef
13.
Zurück zum Zitat Hemminki K, Sundquist J, Brandt A (2011) Familial mortality and familial incidence in cancer. J Clin Oncol 29:712–718PubMedCrossRef Hemminki K, Sundquist J, Brandt A (2011) Familial mortality and familial incidence in cancer. J Clin Oncol 29:712–718PubMedCrossRef
14.
Zurück zum Zitat Hemminki K, Ji J, Försti A, Sundquist J, Lenner P (2008) Concordance of survival in family members with prostate cancer. J Clin Oncol 26:1705–1709PubMedCrossRef Hemminki K, Ji J, Försti A, Sundquist J, Lenner P (2008) Concordance of survival in family members with prostate cancer. J Clin Oncol 26:1705–1709PubMedCrossRef
15.
Zurück zum Zitat Risbridger GP, Davis ID, Birrell SN, Tilley WD (2010) Breast and prostate cancer: more similar than different. Nat Rev Cancer 10:205–212PubMedCrossRef Risbridger GP, Davis ID, Birrell SN, Tilley WD (2010) Breast and prostate cancer: more similar than different. Nat Rev Cancer 10:205–212PubMedCrossRef
16.
Zurück zum Zitat Tryggvadottir L, Vidarsdottir L, Thorgeirsson T et al (2007) Prostate cancer progression and survival in BRCA2 mutation carriers. J Natl Cancer Inst 99:929–935PubMedCrossRef Tryggvadottir L, Vidarsdottir L, Thorgeirsson T et al (2007) Prostate cancer progression and survival in BRCA2 mutation carriers. J Natl Cancer Inst 99:929–935PubMedCrossRef
17.
Zurück zum Zitat Hemminki K, Forsti A, Chen B (2010) Breast and prostate cancer: familial associations. Nat Rev Cancer 10:523PubMedCrossRef Hemminki K, Forsti A, Chen B (2010) Breast and prostate cancer: familial associations. Nat Rev Cancer 10:523PubMedCrossRef
18.
Zurück zum Zitat Brandt A, Sundquist J, Hemminki K (2011) Risk for incident and fatal prostate cancer in men with a family history of any incident and fatal cancer. Ann Oncol (in press) Brandt A, Sundquist J, Hemminki K (2011) Risk for incident and fatal prostate cancer in men with a family history of any incident and fatal cancer. Ann Oncol (in press)
19.
Zurück zum Zitat Johns LE, Houlston RS (2003) A systematic review and meta-analysis of familial prostate cancer risk. BJU Int 91:789–794PubMedCrossRef Johns LE, Houlston RS (2003) A systematic review and meta-analysis of familial prostate cancer risk. BJU Int 91:789–794PubMedCrossRef
20.
Zurück zum Zitat Bruner DW, Moore D, Parlanti A, Dorgan J, Engstrom P (2003) Relative risk of prostate cancer for men with affected relatives: systematic review and meta-analysis. Int J Cancer 107:797–803PubMedCrossRef Bruner DW, Moore D, Parlanti A, Dorgan J, Engstrom P (2003) Relative risk of prostate cancer for men with affected relatives: systematic review and meta-analysis. Int J Cancer 107:797–803PubMedCrossRef
21.
Zurück zum Zitat Thompson IM, Ankerst DP, Tangen CM (2010) Prostate-specific antigen, risk factors, and prostate cancer: confounders nestled in an enigma. J Natl Cancer Inst 102:1299–1301PubMedCrossRef Thompson IM, Ankerst DP, Tangen CM (2010) Prostate-specific antigen, risk factors, and prostate cancer: confounders nestled in an enigma. J Natl Cancer Inst 102:1299–1301PubMedCrossRef
22.
Zurück zum Zitat Bratt O, Garmo H, Adolfsson J et al (2010) Effects of prostate-specific antigen testing on familial prostate cancer risk estimates. J Natl Cancer Inst 102:1336–1343PubMedCrossRef Bratt O, Garmo H, Adolfsson J et al (2010) Effects of prostate-specific antigen testing on familial prostate cancer risk estimates. J Natl Cancer Inst 102:1336–1343PubMedCrossRef
23.
Zurück zum Zitat Lorenzo Bermejo J, Hemminki K (2005) Familial risk of cancer shortly after diagnosis of the first familial tumor. J Natl Cancer Inst 97:1575–1579PubMedCrossRef Lorenzo Bermejo J, Hemminki K (2005) Familial risk of cancer shortly after diagnosis of the first familial tumor. J Natl Cancer Inst 97:1575–1579PubMedCrossRef
24.
Metadaten
Titel
Familial risk and familial survival in prostate cancer
verfasst von
Kari Hemminki
Publikationsdatum
01.04.2012
Verlag
Springer-Verlag
Erschienen in
World Journal of Urology / Ausgabe 2/2012
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-011-0801-1

Weitere Artikel der Ausgabe 2/2012

World Journal of Urology 2/2012 Zur Ausgabe

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.